BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q2 2024

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -0.38% 0.93% 20.13% 0.93% 6.36% -11.66% 0.77% 3.74% 15.72% 04/07/2010
BIB NAV -0.40% 0.82% 19.90% 0.82% 6.23% -11.64% 0.79% 3.73% 15.72% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Gross Expense Ratio 1.15%
  • Net Expense Ratio 0.95%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 4/11/2024
  • NAV $53.69
  • NAV Change $+0.60 up caret
  • Market Price $53.63
  • Market Price Change $+0.65 up caret
  • Trading Volume (M) 9,392
  • 30-Day Median Bid Ask Spread 0.21%
  • View Premium / Discount
Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.15%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 4/11/2024
  • NAV $53.69
  • NAV Change $+0.60 up caret
  • Market Price $53.63
  • Market Price Change $+0.65 up caret
  • Trading Volume (M) 9,392
  • 30-Day Median Bid Ask Spread 0.21%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/24.

Exposures

Index as of 12/29/2023

Holdings

as of 4/11/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
51.52% -- NASDAQ BIO INDEX SWAP BNP 44,255,320 -- 10,323 --
33.45% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 28,736,163 -- 6,703 --
16.64% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 14,293,058 -- 3,334 --
12.10% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 10,391,833 -- 2,424 --
6.59% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,663,206 -- 1,321 --
5.90% AMGN AMGEN INC -- $5,071,950.00 18,785 2023607
5.71% REGN REGENERON PHARMACEUTICALS -- $4,901,624.32 5,326 2730190
5.70% GILD GILEAD SCIENCES INC -- $4,897,696.95 71,343 2369174
5.70% VRTX VERTEX PHARMACEUTICALS INC -- $4,893,211.98 12,226 2931034
5.20% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 4,467,117 -- 1,042 --
3.41% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 2,928,062 -- 683 --
3.13% MRNA MODERNA INC -- $2,684,987.91 25,091 BGSXTS3
3.09% AZN ASTRAZENECA PLC-SPONS ADR -- $2,655,559.65 38,237 2989044
2.26% BIIB BIOGEN INC -- $1,944,125.60 9,545 2455965
1.59% ILMN ILLUMINA INC -- $1,363,593.10 10,433 2613990
1.46% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,258,088.48 8,272 B00FWN1
1.32% BMRN BIOMARIN PHARMACEUTICAL INC -- $1,132,915.02 12,387 2437071
1.05% VTRS VIATRIS INC -- $902,228.60 77,980 BMWS3X9
1.03% NBIX NEUROCRINE BIOSCIENCES INC -- $888,574.41 6,537 2623911
0.99% RPRX ROYALTY PHARMA PLC- CL A -- $852,152.70 29,334 BMVP7Y0
0.98% SNY SANOFI-ADR -- $838,240.80 17,988 2964557
0.95% MEDP MEDPACE HOLDINGS INC -- $813,048.30 2,021 BDCBC61
0.94% INCY INCYTE CORP -- $809,850.32 14,746 2471950
0.90% ARGX ARGENX SE - ADR -- $775,624.95 2,043 BDVLM39
0.89% SRPT SAREPTA THERAPEUTICS INC -- $767,109.80 6,164 B8DPDT7
0.85% UTHR UNITED THERAPEUTICS CORP -- $733,546.08 3,092 2430412
0.69% ROIV ROIVANT SCIENCES LTD -- $591,071.72 52,916 BMW4NZ9
0.66% ASND ASCENDIS PHARMA A/S - ADR -- $569,873.92 3,773 BV9G6B8
0.64% BNTX BIONTECH SE-ADR -- $553,035.56 6,356 BK6H543
0.58% CYTK CYTOKINETICS INC -- $494,837.59 6,761 BBBSBJ5
0.54% JAZZ JAZZ PHARMACEUTICALS PLC -- $464,401.08 4,092 B4Q5ZN4
0.54% PCVX VAXCYTE INC -- $461,330.28 7,116 BKPVGH6
0.53% EXEL EXELIXIS INC -- $450,984.15 19,911 2576941
0.51% APLS APELLIS PHARMACEUTICALS INC -- $441,437.33 7,921 BYTQ6X1
0.50% ITCI INTRA-CELLULAR THERAPIES INC -- $432,289.20 6,360 BHCB0P4
0.47% IONS IONIS PHARMACEUTICALS INC -- $406,895.00 9,574 BDJ0LS6
0.47% RVMD REVOLUTION MEDICINES INC -- $404,663.97 10,817 BL71K91
0.46% BGNE BEIGENE LTD-ADR -- $397,327.47 2,719 BYYWPW6
0.43% BPMC BLUEPRINT MEDICINES CORP -- $371,029.50 4,022 BWY52P3
0.39% KRYS KRYSTAL BIOTECH INC -- $333,968.64 1,856 BD6JX35
0.39% CRSP CRISPR THERAPEUTICS AG -- $331,661.52 5,272 BDHF4K6
0.38% BBIO BRIDGEBIO PHARMA INC -- $327,416.20 11,545 BK1KWG8
0.38% HALO HALOZYME THERAPEUTICS INC -- $327,378.32 8,326 2975098
0.37% MDGL MADRIGAL PHARMACEUTICALS INC -- $320,813.16 1,308 BD59BS7
0.34% IMVT IMMUNOVANT INC -- $293,068.80 9,540 BJRFSB7
0.34% LEGN LEGEND BIOTECH CORP-ADR -- $287,922.34 5,234 BMX9K07
0.32% INSM INSMED INC -- $278,402.88 9,748 2614487
0.32% ALPN ALPINE IMMUNE SCIENCES INC -- $277,306.40 4,306 BYX38M1
0.32% RARE ULTRAGENYX PHARMACEUTICAL IN -- $274,185.60 5,408 BJ62Z18
0.32% ALKS ALKERMES PLC -- $274,140.30 10,970 B3P6D26
0.31% IBRX IMMUNITYBIO INC -- $265,688.58 43,843 BNSP0B8
0.30% NUVL NUVALENT INC-A -- $261,936.00 3,852 BMVBZD3
0.28% IOVA IOVANCE BIOTHERAPEUTICS INC -- $241,917.79 18,341 BF0DMK7
0.27% FTRE FORTREA HOLDINGS INC -- $229,021.41 5,829 BRXYZ57
0.26% AXSM AXSOME THERAPEUTICS INC -- $223,008.57 3,109 BYZR4X4
0.26% CRNX CRINETICS PHARMACEUTICALS IN -- $219,641.19 4,573 BDD19F8
0.25% FOLD AMICUS THERAPEUTICS INC -- $217,611.90 19,395 B19FQ48
0.25% SWTX SPRINGWORKS THERAPEUTICS INC -- $213,624.73 4,843 BGMGM89
0.25% XENE XENON PHARMACEUTICALS INC -- $212,830.41 4,953 BRJ3GY4
0.25% IDYA IDEAYA BIOSCIENCES INC -- $212,693.24 4,894 BK0VHF6
0.24% ARWR ARROWHEAD PHARMACEUTICALS IN -- $208,983.84 8,138 BYQBFJ8
0.24% ACLX ARCELLX INC -- $208,489.05 3,465 BPCJ1Q2
0.22% ACAD ACADIA PHARMACEUTICALS INC -- $188,428.43 10,823 2713317
0.22% SMMT SUMMIT THERAPEUTICS INC -- $185,686.28 46,076 BMTVQS7
0.20% DNLI DENALI THERAPEUTICS INC -- $175,156.29 9,137 BD2B4V0
0.20% VERA VERA THERAPEUTICS INC -- $168,380.18 3,449 BL55460
0.20% RYTM RHYTHM PHARMACEUTICALS INC -- $168,020.68 3,946 BF2YWG4
0.19% ARVN ARVINAS INC -- $166,626.72 4,472 BDZ30Q0
0.19% JANX JANUX THERAPEUTICS INC -- $166,300.00 3,326 BMFX8Y7
0.19% MRUS MERUS NV -- $163,828.18 3,802 BZBY005
0.18% NTLA INTELLIA THERAPEUTICS INC -- $157,888.13 6,313 BYZM6C2
0.18% VCEL VERICEL CORP -- $154,491.12 3,171 BSBMN89
0.17% RCKT ROCKET PHARMACEUTICALS INC -- $150,264.32 5,944 BDFKQ07
0.17% KYMR KYMERA THERAPEUTICS INC -- $149,323.73 4,013 BMPRZV5
0.17% GH GUARDANT HEALTH INC -- $149,309.24 7,993 BFXC911
0.17% KROS KEROS THERAPEUTICS INC -- $146,269.70 2,363 BM7V485
0.17% BEAM BEAM THERAPEUTICS INC -- $146,249.01 5,363 BK6L288
0.17% DYN DYNE THERAPEUTICS INC -- $145,880.64 5,328 BN15WD1
0.16% APGE APOGEE THERAPEUTICS INC -- $141,617.60 2,440 BM9HHL5
0.16% PTCT PTC THERAPEUTICS INC -- $137,794.60 5,029 B17VCN9
0.16% SANA SANA BIOTECHNOLOGY INC -- $135,514.08 14,478 BMFJJ97
0.16% GERN GERON CORP -- $135,173.35 35,855 2370381
0.16% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $133,675.41 2,263 BLCD809
0.15% RXRX RECURSION PHARMACEUTICALS-A -- $133,059.64 14,917 BM9FJ13
0.15% RNA AVIDITY BIOSCIENCES INC -- $132,757.95 5,237 BMWHPY1
0.15% GPCR STRUCTURE THERAPEUTICS INC -- $128,639.00 3,196 BQS9486
0.15% AMPH AMPHASTAR PHARMACEUTICALS IN -- $126,753.55 3,157 BNFWZS4
0.14% SNDX SYNDAX PHARMACEUTICALS INC -- $124,545.60 5,580 BN7Q7R7
0.14% TWST TWIST BIOSCIENCE CORP -- $124,085.96 3,797 BGKG6G7
0.14% MYGN MYRIAD GENETICS INC -- $121,011.50 5,903 2614153
0.14% HRMY HARMONY BIOSCIENCES HOLDINGS -- $116,443.50 3,725 BKSGZN7
0.13% SUPN SUPERNUS PHARMACEUTICALS INC -- $114,912.00 3,591 B72ZBG4
0.13% AGIO AGIOS PHARMACEUTICALS INC -- $112,963.44 3,688 BCBVTX1
0.13% ARDX ARDELYX INC -- $112,628.34 15,282 BN89V40
0.13% INBX INHIBRX INC -- $108,947.22 3,111 BK1MBC3
0.12% PTGX PROTAGONIST THERAPEUTICS INC -- $105,799.50 3,825 BDCBCD8
0.12% DVAX DYNAVAX TECHNOLOGIES CORP -- $103,021.78 8,578 BRJZSK0
0.12% VCYT VERACYTE INC -- $102,240.36 4,932 BFTWZY0
0.12% KURA KURA ONCOLOGY INC -- $102,000.00 5,000 BYZD465
0.12% FUSN FUSION PHARMACEUTICALS INC -- $101,502.72 4,752 BJK0NH0
0.12% EWTX EDGEWISE THERAPEUTICS INC -- $100,819.86 6,114 BKY5JZ8
0.12% MORF MORPHIC HOLDING INC -- $99,570.88 3,284 BK8M4J4
0.12% NVCR NOVOCURE LTD -- $99,263.60 7,030 BYSS4X4
0.11% LGND LIGAND PHARMACEUTICALS -- $94,703.09 1,163 2501578
0.11% ANIP ANI PHARMACEUTICALS INC -- $94,196.13 1,383 BCDWBX6
0.11% AVDL AVADEL PHARMACEUTICALS-ADR -- $94,052.28 5,893 BDTZ028
0.11% ADMA ADMA BIOLOGICS INC -- $93,206.70 14,985 B9NSBM2
0.11% FDMT 4D MOLECULAR THERAPEUTICS IN -- $90,579.00 3,270 BKLXFX5
0.10% TARS TARSUS PHARMACEUTICALS INC -- $86,114.21 2,249 BMH5RL1
0.10% ABCL ABCELLERA BIOLOGICS INC -- $84,205.50 19,225 BL53SR3
0.10% PCRX PACIRA BIOSCIENCES INC -- $83,612.16 3,056 B3X26D8
0.10% IRWD IRONWOOD PHARMACEUTICALS INC -- $82,350.81 10,281 B3MZ6K5
0.10% XNCR XENCOR INC -- $82,346.76 4,013 BGCYWN8
0.10% DCPH DECIPHERA PHARMACEUTICALS IN -- $82,333.60 5,305 BZ1LFB2
0.10% PRTA PROTHENA CORP PLC -- $82,131.84 3,528 B91XRN2
0.10% VIR VIR BIOTECHNOLOGY INC -- $81,912.60 8,865 BK4PZ38
0.10% GMAB GENMAB A/S -SP ADR -- $81,844.48 2,752 BBC9WC7
0.09% AKRO AKERO THERAPEUTICS INC -- $80,720.64 3,696 BK7Y2V9
0.09% DAWN DAY ONE BIOPHARMACEUTICALS I -- $80,648.16 5,736 BLB0YH0
0.09% MIRM MIRUM PHARMACEUTICALS INC -- $79,013.97 3,059 BJDX8Y8
0.09% COLL COLLEGIUM PHARMACEUTICAL INC -- $76,382.61 2,099 BX7RSN3
0.09% MNKD MANNKIND CORP -- $76,355.10 17,757 BF081J4
0.09% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $75,556.80 6,360 BKX9VD3
0.09% MGNX MACROGENICS INC -- $75,428.25 4,075 BFDV8K0
0.09% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $74,612.74 8,686 BMCWKZ2
0.09% EYPT EYEPOINT PHARMACEUTICALS INC -- $73,385.34 3,206 BMGS7L1
0.08% VRNA VERONA PHARMA PLC - ADR -- $72,150.54 4,462 BYWPZK5
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $69,048.90 13,539 2100362
0.08% SRRK SCHOLAR ROCK HOLDING CORP -- $67,137.46 4,738 BFZQ0L8
0.08% SAGE SAGE THERAPEUTICS INC -- $65,451.50 3,950 BP4GNK9
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $64,409.28 2,704 BMFD115
0.07% ZNTL ZENTALIS PHARMACEUTICALS INC -- $62,517.42 4,662 BMQ5T49
0.07% ETNB 89BIO INC -- $62,066.94 6,121 BK1K484
0.07% RLAY RELAY THERAPEUTICS INC -- $61,417.82 8,614 BN2R582
0.07% INVA INNOVIVA INC -- $61,075.92 4,152 BDDXF67
0.07% OCUL OCULAR THERAPEUTIX INC -- $59,938.92 7,239 BNZB1X8
0.07% PACB PACIFIC BIOSCIENCES OF CALIF -- $59,477.86 17,597 B4N8MH9
0.07% SPRY ARS PHARMACEUTICALS INC -- $58,258.20 6,305 BMCR7V2
0.07% PLRX PLIANT THERAPEUTICS INC -- $57,214.38 3,954 BMDWW66
0.07% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $57,172.78 1,757 BKC9SX3
0.06% RGNX REGENXBIO INC -- $55,538.40 2,920 BZ0G875
0.06% NRIX NURIX THERAPEUTICS INC -- $55,244.10 3,210 BMVLGP2
0.06% GRFS GRIFOLS SA-ADR -- $53,253.20 8,008 B8K7T65
0.06% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $52,672.50 2,341 BKDQKM6
0.06% TNGX TANGO THERAPEUTICS INC -- $50,837.82 6,698 BP2P6L0
0.06% IRON DISC MEDICINE INC -- $50,687.28 1,582 BMGJZJ8
0.06% CABA CABALETTA BIO INC -- $50,398.74 2,814 BK5MWR1
0.06% AUTL AUTOLUS THERAPEUTICS PLC -- $49,265.19 9,243 BFMLGR4
0.06% ZLAB ZAI LAB LTD-ADR -- $48,812.52 3,252 BD9GVY0
0.06% CGEM CULLINAN ONCOLOGY INC -- $48,792.33 2,809 BM90J52
0.06% AUPH AURINIA PHARMACEUTICALS INC -- $48,234.60 9,495 BFWLC09
0.06% WVE WAVE LIFE SCIENCES LTD -- $48,072.00 8,012 BYZG9R0
0.06% EOLS EVOLUS INC -- $47,625.57 3,753 BDRJH21
0.06% SVRA SAVARA INC -- $47,461.92 8,888 BYXGN81
0.05% KNSA KINIKSA PHARMACEUTICALS-A -- $46,444.80 2,624 BD0MGM0
0.05% COGT COGENT BIOSCIENCES INC -- $44,690.65 6,823 BLR6XK8
0.05% PRME PRIME MEDICINE INC -- $44,475.55 7,655 BPBJFM7
0.05% LYEL LYELL IMMUNOPHARMA INC -- $44,382.10 16,685 BN6MB18
0.05% VERV VERVE THERAPEUTICS INC -- $44,312.37 5,491 BNKGXX2
0.05% ORIC ORIC PHARMACEUTICALS INC -- $44,240.00 4,424 BKVDFF7
0.05% ALLO ALLOGENE THERAPEUTICS INC -- $44,081.52 11,048 BFZNYB7
0.05% CNTA CENTESSA PHARMACEUTICALS-ADR -- $43,942.74 3,702 BLB0YQ9
0.05% ALXO ALX ONCOLOGY HOLDINGS INC -- $43,792.74 3,273 BLN7XQ1
0.05% CVAC CUREVAC NV -- $43,514.96 14,701 BN4RD42
0.05% ANAB ANAPTYSBIO INC -- $43,178.58 1,746 BDRW1L7
0.05% ZYME ZYMEWORKS INC -- $43,027.92 4,597 BPCQZY9
0.05% SIGA SIGA TECHNOLOGIES INC -- $42,973.86 4,666 2107437
0.05% YMAB Y-MABS THERAPEUTICS INC -- $42,090.51 2,877 BG31GH0
0.05% OLMA OLEMA PHARMACEUTICALS INC -- $41,787.90 3,618 BMZ4LN0
0.05% GLPG GALAPAGOS NV-SPON ADR -- $39,981.60 1,296 B292NQ7
0.05% OABI OMNIAB INC -- $39,691.60 7,633 BN13S71
0.05% TSHA TAYSHA GENE THERAPIES INC -- $39,535.16 12,278 BNC1BX1
0.05% NVAX NOVAVAX INC -- $39,517.00 9,190 BJDQXG4
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $39,377.67 3,761 BJLKVS6
0.05% ALEC ALECTOR INC -- $39,168.01 6,287 BJ4LDC4
0.04% CSTL CASTLE BIOSCIENCES INC -- $37,507.90 1,805 BKLCWZ3
0.04% SLRN ACELYRIN INC -- $36,823.68 6,393 BQPF874
0.04% HCM HUTCHMED CHINA-ADR -- $36,813.15 2,035 BYXV9H7
0.04% MLYS MINERALYS THERAPEUTICS INC -- $35,423.22 2,702 BP9N0G0
0.04% EDIT EDITAS MEDICINE INC -- $35,367.50 5,375 BZ8FPH3
0.04% TRML TOURMALINE BIO INC -- $33,808.20 1,682 BQ80NC6
0.04% TVTX TRAVERE THERAPEUTICS INC -- $33,429.93 4,997 BLFGJD5
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $33,363.33 11,011 BZ0QMB7
0.04% PETQ PETIQ INC -- $33,183.27 1,917 BDH65C8
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $33,045.10 2,731 BD06CS0
0.04% LXRX LEXICON PHARMACEUTICALS INC -- $32,530.75 16,025 BWFZX59
0.04% THRD THIRD HARMONIC BIO INC -- $31,782.94 2,653 BNNPQY8
0.04% FULC FULCRUM THERAPEUTICS INC -- $31,771.08 4,068 BJDX8Z9
0.04% VYGR VOYAGER THERAPEUTICS INC -- $31,300.70 3,565 BY7RB53
0.04% BMEA BIOMEA FUSION INC -- $31,101.76 2,342 BNKF6N0
0.04% HROW HARROW INC -- $30,389.76 2,304 BHNDW86
0.03% TBPH THERAVANCE BIOPHARMA INC -- $29,218.96 3,272 BMNDK09
0.03% REPL REPLIMUNE GROUP INC -- $28,997.27 4,033 BDDVW37
0.03% ITOS ITEOS THERAPEUTICS INC -- $28,880.40 2,348 BMWXFT4
0.03% MRNS MARINUS PHARMACEUTICALS INC -- $28,393.20 3,585 BM8MVZ3
0.03% MXCT MAXCYTE INC -- $28,100.52 6,804 BKMQF66
0.03% ATAI ATAI LIFE SCIENCES NV -- $26,930.41 10,903 BN6M8F1
0.03% URGN UROGEN PHARMA LTD -- $26,884.25 2,029 BZ7PJQ1
0.03% AMRN AMARIN CORP PLC -ADR -- $25,842.72 25,336 2301938
0.03% RVNC REVANCE THERAPEUTICS INC -- $25,716.48 5,792 BJFSR99
0.03% CRBU CARIBOU BIOSCIENCES INC -- $25,148.64 5,808 BNYJR68
0.03% ADPT ADAPTIVE BIOTECHNOLOGIES -- $24,955.50 9,525 BJ5FZ74
0.03% AVXL ANAVEX LIFE SCIENCES CORP -- $23,989.95 5,391 BYTYP72
0.03% MGTX MEIRAGTX HOLDINGS PLC -- $23,917.02 4,174 BFYQFJ2
0.03% PGEN PRECIGEN INC -- $23,703.15 16,347 BKM5C84
0.03% ERAS ERASCA INC -- $22,723.67 9,923 BNLYBF3
0.03% NAUT NAUTILUS BIOTECHNOLOGY INC -- $21,605.45 8,215 BNG1NK8
0.02% AVIR ATEA PHARMACEUTICALS INC -- $21,275.10 5,526 BLN9Z50
0.02% TERN TERNS PHARMACEUTICALS INC -- $21,177.54 4,057 BMDJ0C9
0.02% RAPT RAPT THERAPEUTICS INC -- $21,161.28 2,256 BK5T6R0
0.02% HUMA HUMACYTE INC -- $20,548.08 6,804 BMYTJP4
0.02% XERS XERIS BIOPHARMA HOLDINGS INC -- $18,416.16 9,072 BLR7H87
0.02% VTYX VENTYX BIOSCIENCES INC -- $17,903.20 3,892 BMG99Y1
0.02% ACIU AC IMMUNE SA -- $17,717.70 6,490 BZC0D70
0.02% CHRS COHERUS BIOSCIENCES INC -- $17,621.92 7,312 BRK0149
0.02% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $17,475.15 1,335 BL95N25
0.02% VNDA VANDA PHARMACEUTICALS INC -- $16,161.28 3,776 B12W3P6
0.02% QURE UNIQURE NV -- $15,814.32 3,144 BJFSR88
0.02% EXAI EXSCIENTIA PLC -- $15,554.88 3,168 BP48134
0.02% OVID OVID THERAPEUTICS INC -- $15,176.07 4,641 BYPFK63
0.02% BLUE BLUEBIRD BIO INC -- $14,501.16 12,501 BBFL7S1
0.01% -- ACHILLION PHARMACEUTICALS INC - CVR -- $11,641.22 25,307 --
0.01% AMLX AMYLYX PHARMACEUTICALS INC -- $10,188.21 4,449 BPCK358
0.01% ME 23ANDME HOLDING CO -CLASS A -- $9,562.04 20,715 BM9CKX3
0.01% ACRS ACLARIS THERAPEUTICS INC -- $5,685.20 4,660 BYV2W40
-- RPHM RENEO PHARMACEUTICALS INC -- $3,719.60 2,188 BMHR7T5
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- -- TREASURY BILL -- $14,743,841.70 15,000,000 BRYQ9Y9
-- -- NET OTHER ASSETS (LIABILITIES) -- $9,725,080.17 9,725,080 --

Index

as of 12/29/2023

  • Total Number of Companies225
  • Price/Earnings Ratio--
  • Price/Book Ratio4.289
  • Dividend Yield ( % )0.79
  • Avg. Index Market Capitalization$6.63 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.